United States Respiratory Devices Market Outlook to 2033
Summary
GlobalData’s “United States Respiratory Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Respiratory Device Accessories, Ventilators, Positive Airway Pressure Devices, Non-Invasive Ventilation Masks & Circuits
The United States Respiratory Devices Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Respiratory Devices Market.
Global corporate-level profiles of key companies operating within the United States Respiratory Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Respiratory Devices
Respiratory Device Accessories
Ventilators
Positive Airway Pressure Devices
Non-Invasive Ventilation Masks & Circuits
Reasons to Buy
The United States Respiratory Devices Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Respiratory Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Respiratory Devices Market, United States
3.1 Respiratory Devices Market, United States, Revenue ($m), 2018-2033
3.1.1 Non-Invasive Ventilation Masks & Circuits Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Positive Airway Pressure Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Respiratory Device Accessories Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.4 Ventilators Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Respiratory Devices Market, United States, Volume (Units), 2018-2033
3.2.1 Non-Invasive Ventilation Masks & Circuits Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Positive Airway Pressure Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Respiratory Device Accessories Market, United States, Volume (Units), by Segment, 2018-2033
3.2.4 Ventilators Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Respiratory Devices Market, United States, Average Price ($) , 2018-2033
3.4 Respiratory Devices Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Respiratory Devices Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Respiratory Devices Market
4.1 ResMed Inc
4.1.1 Company Overview
4.2 Philips Respironics Inc
4.2.1 Company Overview
4.3 Fisher & Paykel Healthcare Corporation Ltd
4.3.1 Company Overview
4.4 Medtronic Plc
4.4.1 Company Overview
4.5 Vyaire Medical Inc
4.5.1 Company Overview
4.6 Koninklijke Philips NV
4.6.1 Company Overview
4.7 Maquet AG
4.7.1 Company Overview
4.8 ICU Medical Inc
4.8.1 Company Overview
4.9 Hamilton Medical AG
4.9.1 Company Overview
5 Respiratory Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Owens & Minor to Acquire Rotech Healthcare Holdings for USD1.36 Billion
6.1.2 Medtronic Acquires Michigan Critical Care Consultants (MC3 Cardiopulmonary)
6.1.3 Integra LifeSciences Acquires Acclarent for USD275 Million
6.2 Asset Transactions
6.2.1 Zoll Medical Acquires Ventilator Business from Vyaire Medical
6.3 Equity Offerings
6.3.1 GE HealthCare Technologies to Raise Funds in Secondary Offering of Shares
6.3.2 GE HealthCare Technologies Prices to Raise USD1.29 Billion in Upsized Secondary Offering of Shares
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 18, 2024: Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
7.1.2 Sep 19, 2024: ILC Dover's SCape CO/CBRN 30 Escape Respirator Receives CE and UKCA Certification, Setting New Standard for Respiratory Protection
7.1.3 Sep 05, 2024: Inogen Names Eric Pauls as Vice President of Sales, North America
7.1.4 Aug 15, 2024: ResMed Announces Expansion of Board of Directors
7.1.5 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
7.2.6 May 07, 2024: Kimball Electronics Reports Q3 Results; Company Announces Renewed Strategic Focus, Including Expected Divestiture of the Automation, Test & Measurement Business
7.2.7 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
7.2.8 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024
7.2.9 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.3 Government and Public Interest
7.3.1 Jun 03, 2024: Electromed to Participate in the 2024 Sidoti June Small-Cap Virtual Conference
7.3.2 Jun 03, 2024: Kimball Electronics Appoints New Treasurer
7.3.3 Feb 22, 2024: Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
7.3.4 Feb 22, 2024: ARC Medical Announces Participation in Premier 2024 H1 Life Sciences Conferences
7.3.5 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
7.4 Legal And Regulatory
7.4.1 Apr 30, 2024: Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire
7.4.2 Apr 30, 2024: Inside Information, Optomed Aurora with AEYE has Received FDA Clearance in the US
7.4.3 Dec 14, 2023: Dongguan Simzo Electronic Technology Receives FDA 510(k) Clearance for SIMZO Ultrasonic Nebulizer
7.5 Other Significant Developments
7.5.1 Nov 21, 2024: Merck Data of MK-3543 at the ASH 2024 Promising Hematology Pipeline with Diverse Range of Investigational Assets and Novel Modalities
7.6.3 Jan 08, 2024: Using AI to Identify High-Risk Patients With Asthma and COPD
7.7 Strategy And Business Planning
7.7.1 Oct 16, 2024: Journal of Clinical Medicine Publication Demonstrates Clinical Utility of SeptiCyte RAPID in Critically Ill Heterogeneous Patient Populations
7.7.2 Apr 03, 2024: Adherium Partners with Rimidi to Revolutionise Respiratory Clinical Management Solutions